Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2012
11/27/2012US8318208 Drug loaded polymeric nanoparticles and methods of making and using same
11/27/2012US8318207 Encapsulation and controlled release of small molecules for intracellular delivery using thermally responsive nanocapsules
11/27/2012US8318206 Particles
11/27/2012US8318205 Polyethylene glycol/polycation block copolymers
11/27/2012US8318204 pH sensitive block copolymer and polymeric micelle using the same
11/27/2012US8318203 Form of administration of racecadotril
11/27/2012US8318202 Stable compositions of famotidine and ibuprofen
11/27/2012US8318201 Method of stabilizing diarylvinylene compound
11/27/2012US8318200 Pharmaceutical composition of nanoparticles
11/27/2012US8318199 Liposome for liver-specific delivery and release of therapeutic nucleic acids or drugs
11/27/2012US8318194 Implants for administering substances and methods of producing mesoporous implants
11/27/2012US8318192 Method of making load bearing hydrogel implants
11/27/2012US8318189 Capsule medication administration system and medication administration method
11/27/2012US8318186 Use of at least a fatty ester for preparing a composition designed to inhibit 5-α-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive
11/27/2012US8318181 Botulinum nanoemulsions
11/27/2012US8318142 Method of stimulating hair growth
11/27/2012US8318136 Methods and systems for neural maintenance and regeneration
11/27/2012US8318070 Ocular implant made by a double extrusion process
11/27/2012US8317776 Circulatory monitoring systems and methods
11/27/2012US8317737 Device for actively removing a target component from blood or lymph of a vertebrate subject
11/27/2012US8317681 Endoscopic smart probe and method
11/27/2012US8317516 Dental mill blanks
11/27/2012CA2689358C Peptide pharmaceutical for oral delivery
11/27/2012CA2599334C External plaster containing flurbiprofen
11/27/2012CA2573696C Liposome allowing liposome-entrapped substance to escape from endosome
11/27/2012CA2564542C Combination formulations of anthracycline agents and cytidine analogs
11/27/2012CA2563440C Orally disintegrating tablets and methods of manufacture
11/27/2012CA2558212C Interferon-beta for anti-virus therapy for respiratory diseases
11/27/2012CA2556815C Skincare compositions comprising salicylic acid
11/27/2012CA2542663C Microemulsions of retinoids, and pharmaceutical compositions containing them
11/27/2012CA2514636C Adhesive material and adhesive preparation
11/27/2012CA2513720C Method and apparatus for treating bodily tissues with medicinal substance
11/27/2012CA2481390C Nanoparticulate megestrol formulations
11/27/2012CA2470771C Medical device for fluid delivery having low fluid flow rate
11/27/2012CA2181832C Immunization by inoculation of dna transcription unit
11/23/2012DE202012009981U1 Maskierungskörper zur dosierten Verabreichung eines Arzneimittels Masking body for the dosed administration of a drug
11/22/2012WO2012159064A1 High concentration olopatadine ophthalmic composition
11/22/2012WO2012158527A2 Organophosphorous & multivalent metal compound compositions & methods
11/22/2012WO2012158510A1 Container closure system with integral antimicrobial additives
11/22/2012WO2012158312A2 Skin and hair regeneration using polysaccharide-based hydrogels
11/22/2012WO2012158166A1 Compositions, methods & systems for respiratory delivery of two or more active agents
11/22/2012WO2012158127A2 Water-soluble formulations comprising dexketoprofen
11/22/2012WO2012158030A2 Drug delivery system
11/22/2012WO2012157752A1 Pharmaceutical composition containing loxoprofen
11/22/2012WO2012157721A1 Liposome containing pyrroloquinoline quinone and sugar
11/22/2012WO2012156999A1 Ready to use docetaxel formulation
11/22/2012WO2012156997A2 Multi-particulate pharmaceutical composition
11/22/2012WO2012156981A1 Pharmaceutical compositions of lurasidone
11/22/2012WO2012156822A1 Controlled release nasal testosterone gels, methods and pre-filled multi-dose applicator systems for pernasal administration
11/22/2012WO2012156821A1 Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
11/22/2012WO2012156820A1 Intranasal testosterone bio-adhesive gel formulations and use thereof for treating male hypogonadism
11/22/2012WO2012156711A1 Pharmaceutical compositions
11/22/2012WO2012156599A1 The use of secnidazole in treating dental infections
11/22/2012WO2012156561A1 Controlled-release injectable microparticle
11/22/2012WO2012156527A1 Pharmaceutical composition having improved bioavailability
11/22/2012WO2012156372A1 Intraocular tissue staining system
11/22/2012WO2012156317A2 Intranasal pharmaceutical dosage forms comprising naloxone
11/22/2012WO2012156094A1 Nanoparticles functionalized with dendritic polyglycerol sulfate
11/22/2012WO2012156065A1 Method for making customised nanoparticles, nanoparticles and uses thereof
11/22/2012WO2012155920A1 Charge triggering of self-organized nanoparticles
11/22/2012WO2012155827A1 Use of indole-2,3-dione in preparing medicine for improving dyszoospermia
11/22/2012WO2012155809A1 Edible liquid filled polysaccharide capsules
11/22/2012WO2012155261A1 Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response
11/22/2012WO2012135619A3 Intranasal benzodiazepine pharmaceutical compositions
11/22/2012WO2012135010A3 Osmotic mediated release synthetic nanocarriers
11/22/2012WO2012129568A3 Lithium compositions
11/22/2012WO2012109605A8 Forms of rifaximin and uses thereof
11/22/2012WO2012106713A3 Targeted nanoparticle conjugates
11/22/2012WO2012085656A3 Encased tamper resistant controlled release dosage forms
11/22/2012WO2012081954A3 Broad-spectrum local antiseptic solution based on sodium hypochlorite, sodium bicarbonate, chloramphenicol, soap and 0.9% saline solution
11/22/2012WO2012080918A3 Wear resistant antimicrobial compositions and methods of use
11/22/2012WO2011161247A3 Dental care chewing gum comprising silver moieties
11/22/2012WO2011124895A3 Phospholipid-containing pharmaceutical and nutraceutical compositions
11/22/2012US20120296312 Device and method for combining a treatment agent and a gel
11/22/2012US20120296274 Delivery of coated hydrophobic active agent particles
11/22/2012US20120295988 Pharmaceutical Compositions of Dispersions of Amorphous Drugs Mixed with Polymers
11/22/2012US20120295945 Buccal, polar and non-polar spray containing ondansetron
11/22/2012US20120295867 Method and pharmaceutical to treat spinal discs
11/22/2012US20120295848 Sustained-release composition and process for producing the same
11/22/2012US20120295836 GLP-I Agonist And Cardiovascular Complications
11/22/2012US20120294948 Vaccine
11/22/2012US20120294947 Oral Preparation Having Improved Quality
11/22/2012US20120294946 Modulator
11/22/2012US20120294945 Drug delivery system using hyaluronic acid-peptide conjugate micelle
11/22/2012US20120294944 Sustained-release nucleic acid matrix compositions
11/22/2012US20120294943 Extended-release formulation for reducing the frequency of urination and method of use thereof
11/22/2012US20120294942 Novel process for the preparation of roflumilast
11/22/2012US20120294941 Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process
11/22/2012US20120294940 Rapidly disintegrating tablet in oral cavity
11/22/2012US20120294939 Direct compression formulation and process
11/22/2012US20120294938 Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and method for its production
11/22/2012US20120294937 New pharmaceutical dosage form for the treatment of gastric acid-related disorders
11/22/2012US20120294936 Reduced mass metformin formulations
11/22/2012US20120294935 Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same
11/22/2012US20120294934 Transdermal compositions for anticholinergic agents
11/22/2012US20120294933 Use of PVP-Iodine Liposomes for Treatment of Acne
11/22/2012US20120294932 Prostate Carcinogenesis Predictor
11/22/2012US20120294931 Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof
11/22/2012US20120294930 Combination of kinase inhibitors and uses thereof
11/22/2012US20120294929 Method of diagnosing and treating cancer using b-catenin splice variants
1 ... 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 ... 2991